🇺🇸 FDA
Pipeline program

rhPTH(1-84)

SHP634-301

Approved small_molecule terminated

Quick answer

rhPTH(1-84) for Chronic Hypoparathyroidism is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Hypoparathyroidism
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials